Mirae Asset Global ETFs Holdings
EBS icon

Mirae Asset Global ETFs Holdings’s Emergent Biosolutions EBS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
29,495
-1,282
-4% -$10.7K ﹤0.01% 2376
2026
Q1 		$254K Buy
30,777
+1,334
+5% +$13.8K ﹤0.01% 2226
2025
Q4 		$363K Sell
29,443
-760
-3% -$8.14K ﹤0.01% 2049
2025
Q3 		$267K Sell
30,203
-3,155
-9% -$24.5K ﹤0.01% 2167
2025
Q2 		$213K Buy
33,358
+28,185
+545% +$161K ﹤0.01% 2252
2025
Q1 		$24.1K Sell
5,173
-554
-10% -$4.59K ﹤0.01% 2962
2024
Q4 		$53K Buy
5,727
+57
+1% +$523 ﹤0.01% 2893
2024
Q3 		$42.5K Sell
5,670
-20,362
-78% -$185K ﹤0.01% 2950
2024
Q2 		$178K Buy
+26,032
New +$112K ﹤0.01% 2314

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's EBS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Emergent Biosolutions (EBS) stake by 4.2% in Q2 2026, selling an estimated $10.7K and leaving 29,495 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Mirae Asset Global ETFs Holdings first reported a position in EBS in Q2 2024 and has held it in 9 quarters since. The position peaked at $363K in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 29,495 shares of Emergent Biosolutions worth $248K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,282 Emergent Biosolutions shares in Q2 2026, an estimated $10.7K.
  • Emergent Biosolutions made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2376 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Emergent Biosolutions position peaked at $363K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.